Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP814094.RASLlU38vRD8IeYK42MQ7JVXzxvz2Kgml3xHUiB-5MHsg130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP814094.RASLlU38vRD8IeYK42MQ7JVXzxvz2Kgml3xHUiB-5MHsg130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP814094.RASLlU38vRD8IeYK42MQ7JVXzxvz2Kgml3xHUiB-5MHsg130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP814094.RASLlU38vRD8IeYK42MQ7JVXzxvz2Kgml3xHUiB-5MHsg130_provenance.
- NP814094.RASLlU38vRD8IeYK42MQ7JVXzxvz2Kgml3xHUiB-5MHsg130_assertion description "[The RAF kinase inhibitor sorafenib suppresses ATF5 expression in glioma stem cells and inhibits malignant glioma growth in cell culture and mouse models.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP814094.RASLlU38vRD8IeYK42MQ7JVXzxvz2Kgml3xHUiB-5MHsg130_provenance.
- NP814094.RASLlU38vRD8IeYK42MQ7JVXzxvz2Kgml3xHUiB-5MHsg130_assertion evidence source_evidence_literature NP814094.RASLlU38vRD8IeYK42MQ7JVXzxvz2Kgml3xHUiB-5MHsg130_provenance.
- NP814094.RASLlU38vRD8IeYK42MQ7JVXzxvz2Kgml3xHUiB-5MHsg130_assertion SIO_000772 20495567 NP814094.RASLlU38vRD8IeYK42MQ7JVXzxvz2Kgml3xHUiB-5MHsg130_provenance.
- NP814094.RASLlU38vRD8IeYK42MQ7JVXzxvz2Kgml3xHUiB-5MHsg130_assertion wasDerivedFrom befree-2016 NP814094.RASLlU38vRD8IeYK42MQ7JVXzxvz2Kgml3xHUiB-5MHsg130_provenance.
- NP814094.RASLlU38vRD8IeYK42MQ7JVXzxvz2Kgml3xHUiB-5MHsg130_assertion wasGeneratedBy ECO_0000203 NP814094.RASLlU38vRD8IeYK42MQ7JVXzxvz2Kgml3xHUiB-5MHsg130_provenance.
- befree-2016 importedOn "2016-02-19" NP814094.RASLlU38vRD8IeYK42MQ7JVXzxvz2Kgml3xHUiB-5MHsg130_provenance.